Clinical Development Pipeline

Program
Indications
Current Phase Preclinical Phase 1 Phase 2 Phase 3
Worldwide
rights
KINETIC
COVID-19 hospitalized patients
(severe)
 
Kinarus AG
KINFAST
COVID-19 ambulatory patients
(mild-to-moderate)
 
Kinarus AG
KIN001-AMD
Wet-AMD patients
(maintenance of vision)
 
Kinarus AG
KIN001-IPF
Idiopathic Pulmonary Fibrosis
(rare lung disease)
 
Kinarus AG